BLISSGVS vs WANBURY: Stock Comparison

BLISSGVS vs WANBURYUpdated 2 Jul 26, 4:08 PM ISTNSE & company filings

BLISSGVS is the larger company by market capitalisation. BLISSGVS shows a higher dividend yield, faster revenue growth and lower leverage, while WANBURY shows a lower P/E, a higher ROE and a higher ROCE. These are relative readings on individual metrics — weigh valuation against growth, margins, leverage and capital efficiency rather than treating any single number as decisive.

Metric snapshot

BLISSGVS leads 8; WANBURY leads 5 of 13

Not a rating

Interactive comparison

Compare the numbers that shape the decision

Every row uses its own scale. Switch lenses to compare like with like.

BLISSGVSWANBURY

Valuation lens

What price are you paying?

Market CapContext only
₹7,678 Cr
₹832 Cr
P/E RatioWANBURY has the lower reading
56.25x
0x
P/B RatioWANBURY has the lower reading
6.42x
0x
EPSBLISSGVS has the higher reading
₹3.64
₹0.93
Book ValueContext only
₹116.14
₹41.34
Dividend YieldBLISSGVS has the higher reading
0.21%
0%

✓ marks the usual favourable reading; it is not a recommendation.

Key Differences

Market Cap
BLISSGVS is the larger company
₹7,678 Cr vs ₹832 Cr
P/E Ratio
WANBURY has a lower P/E
0x vs 56.25x
P/B Ratio
WANBURY has a lower P/B
0x vs 6.42x
EPS
BLISSGVS has higher earnings per share
₹3.64 vs ₹0.93
Dividend Yield
BLISSGVS has a higher dividend yield
0.21% vs 0%
Revenue Growth (TTM YoY)
BLISSGVS has faster revenue growth
29.8% vs -19.2%
EPS Growth (TTM YoY)
BLISSGVS has faster EPS growth
124.7% vs 0%
Qtr Sales Growth
WANBURY has stronger quarterly sales growth
0.61% vs -22.41%

Each difference is a single, relative reading — StockeZee does not name an overall winner.

Profile

MetricBLISSGVSWANBURY
SectorHealthcareHealthcare
IndustryPharmaceuticalsPharmaceuticals

Price

MetricBLISSGVSWANBURY
Live Price₹527.1₹239.35
Day Change0.68%-0.87%
Volume3.93 L59,568
52-Week High₹553₹358.85
52-Week Low₹118₹161.5
Distance from 52W High-4.68%-33.3%

Valuation

MetricBLISSGVSWANBURY
Market Cap₹7,678 Cr₹832 Cr
P/E Ratio56.25x0x
P/B Ratio6.42x0x
EPS₹3.64₹0.93
Book Value₹116.14₹41.34
Dividend Yield0.21%0%

Growth

MetricBLISSGVSWANBURY
Revenue Growth (TTM YoY)29.8%-19.2%
EPS Growth (TTM YoY)124.7%0%
Qtr Sales Growth-22.41%0.61%
Qtr Profit Growth-24.83%-85.06%

Profitability & Leverage

MetricBLISSGVSWANBURY
ROE10.94%45.78%
ROCE11.94%25.06%
Net Margin13.93%10.17%
Operating Margin21.74%13.81%
Debt to Equity0x1.49x

Shareholding

As of Jun 2026 • change vs previous quarter
MetricBLISSGVSWANBURY
Promoter Holding35.01% 0.35 pp34.36%
FII Holding8.07% 2.38 pp0.89% 0.3 pp
DII Holding9.47% 4.43 pp0.06% 0.06 pp
Public Holding47.45% 1.7 pp56.03% 0.36 pp

How to Read This Comparison

Valuation ratios (P/E, P/B) use the latest consolidated figures where available; growth numbers compare against the same period last year; shareholding percentages come from the most recent quarterly filings, with the change shown against the prior quarter. A "more favourable" highlight is relative between these two companies only — it is not a rating, a recommendation, or a comparison against the wider sector. Rows with no reported data for either company are hidden rather than shown empty.

Deep-dive each company on its stock page for quarterly results, technicals, filings and the full peer set: BLISSGVS and WANBURY.

Data source: NSE and company filings via StockeZee. This comparison is informational — it is not investment advice, and StockeZee is not a SEBI-registered investment adviser.